Ironwood Pharmaceuticals, Inc.

NASDAQ:IRWD

3.74 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 442.735410.596413.753389.523428.413346.639298.276273.957149.55576.43622.881150.24565.87143.85736.10222.21610.4643.14
Cost of Revenue 104.7851.4181.5233.13623.87532.75119.4061.8680.01225.5837.2030.965000003.14
Gross Profit 337.95409.178412.23386.387404.538313.888278.87272.089149.54350.85315.678149.2865.87143.85736.10222.21610.4640
Gross Profit Ratio 0.7630.9970.9960.9920.9440.9060.9350.99310.6650.6850.994111110
Reseach & Development Expenses 116.08544.26570.40588.062115.044166.503148.228139.492108.746101.89102.378113.47486.09377.45484.89259.80957.24635.543
General & Administrative Expenses 00000241.291233.123173.281125.247118.333123.22892.53845.9227.16923.98000
Selling & Marketing Expenses 000000000000000000
SG&A 158.314115.994111.133140.003172.45241.291233.123173.281125.247118.333123.22892.53845.9227.16923.9818.32810.8335.933
Other Expenses 1,008.981000.0240.5148.1116.2140.98117.6380.66142.07416.030023.9818.32810.8330
Operating Expenses 1,283.38160.259181.538228.065287.494415.905387.565313.754233.993220.223267.68222.042132.013104.623108.87278.13768.07941.476
Operating Income -945.43250.337232.259142.94120.123-238.892-77.385-51.87-102.088-169.37-252.002-72.762-66.142-60.766-72.77-55.921-57.615-39.595
Operating Income Ratio -2.1350.610.5610.3670.28-0.689-0.259-0.189-0.683-2.216-11.014-0.484-1.004-1.386-2.016-2.517-5.506-12.61
Total Other Income Expenses Net -2.6392.085-31.602-34.079-61.18-43.476-71.164-29.838-40.581-20.248-20.810.1381.2931.411-0.8380.894.4552.316
Income Before Tax -948.069252.422200.657108.86158.943-282.368-116.937-81.708-142.669-189.618-272.812-72.624-64.849-59.355-73.608-55.031-53.16-37.279
Income Before Tax Ratio -2.1410.6150.4850.2790.138-0.815-0.392-0.298-0.954-2.481-11.923-0.483-0.984-1.353-2.039-2.477-5.08-11.872
Income Tax Expense 83.4977.357-327.7912.68574.257-5.75234.25937.98419.0238.578-11.729-11.3250.003-2.944-0.296-0.823-0.1450
Net Income -1,002.239175.065528.448106.176-15.314-282.368-116.937-81.708-142.669-189.618-272.812-72.624-64.852-52.981-71.185-53.874-52.752-37.18
Net Income Ratio -2.2640.4261.2770.273-0.036-0.815-0.392-0.298-0.954-2.481-11.923-0.483-0.985-1.208-1.972-2.425-5.041-11.841
EPS -6.451.133.260.67-0.098-1.85-0.79-0.56-1-1.39-2.35-0.68-0.65-0.59-10-7.82-7.41-0.39
EPS Diluted -6.450.943.210.66-0.098-1.85-0.78-0.56-1-1.39-2.35-0.68-0.65-0.59-0.94-7.82-0.7-0.39
EBITDA -924.865261.438233.33141.903101.125-144.452-33.117-31.295-99.943-156.121-240.081-61.24-54.787-52.998-67.277-51.848-51.166-35.803
EBITDA Ratio -2.0890.6330.5630.410.281-0.271-0.344-0.149-0.565-2.216-11.014-0.484-0.845-1.418-1.864-2.293-4.947-11.402